PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97098208 |
Filing Date: 10/28/2021 |
Input Field |
Entered |
TEAS Plus | YES |
---|---|
MARK INFORMATION | |
*MARK | Coronavirus |
*STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | Coronavirus |
*MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Orzechowski, Michelle C |
*MAILING ADDRESS | 20637 Helen Court |
*CITY | Lutz |
*STATE (Required for U.S. applicants) |
Florida |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
33558 |
PHONE | 813-352-2734 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
*TYPE | INDIVIDUAL |
* COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF CITIZENSHIP | United States |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
*INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Vaccine research and development; Providing information about medical research in the field of Coronavirus; Providing information about medical research in the field of Immune system; Research and development of vaccines; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines |
*FILING BASIS | SECTION 1(b) |
ADDITIONAL STATEMENTS INFORMATION | |
*TRANSLATION (if applicable) |
|
*TRANSLITERATION (if applicable) |
|
*CLAIMED PRIOR REGISTRATION (if applicable) |
|
*CONSENT (NAME/LIKENESS) (if applicable) |
|
*CONCURRENT USE CLAIM (if applicable) |
|
CORRESPONDENCE INFORMATION | |
NAME | Orzechowski, Michelle C |
DOCKET/REFERENCE NUMBER | 88790444 |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | morzechowski4122014@gmail.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | Morzechowski4122014@gmail.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Plus |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 250 |
*TOTAL FEES DUE | 250 |
*TOTAL FEES PAID | 250 |
SIGNATURE INFORMATION | |
* SIGNATURE | /MichelleCaroleOrzechowski/ |
* SIGNATORY'S NAME | Michelle Carole Orzechowski |
* SIGNATORY'S POSITION | Owner |
SIGNATORY'S PHONE NUMBER | 813-352-2734 |
* DATE SIGNED | 10/28/2021 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97098208 |
Filing Date: 10/28/2021 |
The applicant's current Correspondence Information: |
Orzechowski, Michelle C |
PRIMARY EMAIL FOR CORRESPONDENCE: morzechowski4122014@gmail.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): Morzechowski4122014@gmail.com The docket/reference number is 88790444. Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|